Cepharanthine (CEP) is a natural bisbenzylisoquinoline alkaloid known for its antibacterial, antiviral, and anti-inflammatory activities. Its antifungal effect, however, has not been well studied. In this work, we used machine learning-based virtual screening with Random Forest, Neural Network, and Support Vector Machine models to identify potential inhibitors of Fusarium solani. CEP was selected as a candidate and tested experimentally. The results showed that it inhibited the growth of Fusarium solani, Fusarium proliferatum, Fusarium oxysporum, Alternaria alternata, and Botrytis cinerea. It also reduced the sporulation and spore germination of Fusarium solani and disrupted its redox balance. Transcriptome analysis showed changes in gene expression related to basic metabolic pathways. Molecular docking suggested that CEP binds to the FsCFEM1 protein, and molecular dynamics simulations confirmed stable binding, with key roles for residues THR748 and LEU950. These results suggest that CEP is a potential bio-based antifungal agent and provide novel insights into its mechanism against Fusarium solani.
Fumarase plays a pivotal role in the tricarboxylic acid cycle, but its functions in plant pathogenic fungi are not well understood. We identified two fumarase genes in Fusarium proliferatum and generated individual deletion mutants. Loss of FpFumB led to defects in growth, sporulation, stress tolerance, and virulence. Exogenous malate supplementation restored growth defects. Site-directed mutagenesis of residues G452 and A463 reduced FpFumB enzyme activity. Transcriptomic analysis identified significant changes in gene expression related to different metabolic pathways. Protein interaction assays showed that FpFumB interacts with the DNA repair protein FpSae2. Both ΔFpFumB and ΔFpSae2 mutants displayed altered sensitivity to DNA-damaging agents and reduced virulence, indicating that FpFumB modulates DNA repair and pathogenicity through its interaction with FpSae2. Together, these findings highlight FpFumB as a key regulator of basic biological processes, DNA damage repair, and virulence in Fusarium proliferatum.
Effective cancer therapy remains challenging due to poor tumor specificity, low drug bioavailability, and systemic toxicity of conventional treatments. Herein, we develop a glutathione (GSH)-responsive nanodrug, PEG-SS-PCL@Fe-DOX, which synergistically combines ferroptosis and chemotherapy to achieve enhanced antitumor efficacy. This nanosystem employs a disulfide-linked amphiphilic polymer (PEG-SS-PCL) to encapsulate the Fe-DOX complex, enabling GSH-triggered, tumor-specific drug release. In the tumor microenvironment, cleavage of disulfide bonds facilitates the release of DOX and Fe2+, where DOX intercalates into DNA to inhibit proliferation, and Fe2+ catalyzes Fenton reactions and suppresses GPX4 activity, collectively inducing excessive reactive oxygen species production and ferroptosis. This synergistic mechanism markedly improves therapeutic efficiency, offering a promising strategy for precise and effective cancer treatment.